NESHAR
Cadila set to buy US firm for $171 millionSentynl acquires, develops and commercialises prescription products, according to the company's website. It holds rights for opioid-based d...- Zydus Cadila buys out Biochem PharmaceuticalsZydus Cadila has acquired 100% stake in Mumbai-based Biochem Pharmaceuticals for an undisclosed amount.
- Load More